Those who were eligible, had an aortic valve annulus area of ≤430mm as per the computed tomography measurements, and “suitable” anatomy for transfemoral TAVR with either an Evolut PRO/PRO+/FX or a ...

The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs and is entering commercialization stage for its TAVR (AR) product ...

Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular ...

The SMART two-year data demonstrated that Evolut TAVR continues to show significantly less BVD, which can be a predictor of adverse outcomes, compared to SAPIEN TAVR. Additional results ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...

Medtronic transcatheter aortic valve replacement (TAVR ... Philips's AI-driven software, capable of analyzing aortic anatomy using data obtained from 3D transesophageal echocardiography (3D TEE) and ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR ...